SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Virgin Galactic Holdings, Inc. is an aerospace and space travel company, which engages in the provision of consumer space experience using reusable spaceflight systems. The firm is also involved in designing, developing, and manufacturing, ground and flight testing, spaceflight operation, and post-flight maintenance of spaceflight systems. The company was founded on May 5, 2017 and is headquartered in Tustin, CA.

Virgin Galactic Holdings Inc - Ordinary Shares - Class A

Virgin Galactic Holdings Inc

Virgin Galactic is experiencing intense retail-driven momentum as investors speculate on potential synergies and sector hype surrounding the upcoming SpaceX IPO. While the community is actively debating the company's long-term viability and short-squeeze potential, many are aggressively positioning for further volatility leading up to the scheduled space-sector milestones.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is trending as retail investors and traders continue to pile into the stock, driven by massive momentum in the semiconductor sector, intense AI speculation, and institutional buying. The community is actively debating the stock's astronomical valuation and price-to-earnings ratios, with bears calling it a manipulated bubble while bulls point to Arm's role as a foundational architecture in the expanding global AI infrastructure.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is trending due to the launch of its own stablecoin and building speculation regarding a potential S&P 500 inclusion, which has fueled significant retail interest and short-squeeze chatter. While the stock's high volatility and periodic pullbacks remain a key talking point for the community, many investors are actively discussing the firm's transition into a comprehensive financial super app as a long-term growth catalyst.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is experiencing extreme bullish sentiment driven by a structural shift in memory demand, as the industry pivots toward long-term supply contracts to address critical HBM and DRAM shortages. Community discussions are centered on an aggressive rerating of the stock, with investors actively debating parabolic price targets and the potential for a stock split as the company solidifies its position as a primary beneficiary of the AI infrastructure supercycle.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is seeing intense community enthusiasm and a significant price breakout as investors increasingly recognize the integration of its QNX safety-certified software into the foundational architecture of the Physical AI and robotics sectors. The stock is currently benefiting from heavy institutional interest, a record backlog in its IoT division, and speculation surrounding upcoming industry conferences and earnings, with the community actively tracking strong volume and potential gamma squeeze indicators.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Revolution Medicines is trending following news that Merck has paused acquisition talks due to valuation disagreements, leading to volatility as investors re-evaluate the stock's standalone potential and pipeline milestones. The community remains focused on the company's progress with its RAS(ON) inhibitor pipeline and continues to discuss the likelihood of other potential suitors emerging.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is seeing increased market attention following government backing for its quantum computing and infrastructure initiatives, leading to heavy discussion around its potential to lead the quantum sector. The community is actively debating whether these strategic catalysts justify the stock's recent volatility and upward price momentum or if it is part of a broader trend of speculative rotation into quantum and AI-related tech.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is currently trending as a critical pillar of the AI hardware "Iron Triangle," with investors heavily focused on its dominant position in custom ASIC silicon and networking infrastructure ahead of its upcoming earnings report. The community is actively debating whether the stock's recent consolidation and price target hikes signal further breakout potential toward new highs or if the high market expectations for AI-driven growth create a risk of a short-term reset.

Hyperliquid Strategies, Inc. is a holding and operating company, which engages in the business of crypto asset management. The firm operates as a digital asset treasury company which focuses on the Hyperliquid ecosystem. The company was founded on July 2, 2025 and is headquartered in New York, NY.

Hyperliquid Strategies Inc.

Hyperliquid Strategies is attracting significant investor attention as the $PURR ticker experiences high volatility and speculative volume driven by its direct exposure to the HYPE token. The community is actively discussing the stock's potential for a short squeeze and institutional adoption, while remaining sharply divided over the risks associated with its treasury model versus pure crypto market exposure.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is trending as investors aggressively rotate into enterprise software, viewing the stock as a discounted opportunity with strong AI monetization potential through tools like Firefly. While community sentiment remains polarized between long-term holders betting on institutional buybacks and those fearing AI disruption, many are actively monitoring the stock's support levels as it aligns with broader bullish patterns in the SaaS sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$MLTX 
Today, as expected, all positive news. By July they&#39;ll report expedited approval process from the FDA on top of additional positive trial results. 

SLK is the only small molecule NanoBody for Inflammatory skin diseases, this simply places it as superior to everything else.

There&#39;s literally nothing standing in SLK&#39;s path to becoming Best in Class across all Inflammatory skin disease indications. Furthermore, we have zero concern of dilution which almost always happens during phase 3 trials nearing drug BLA submission. 

Wouldn&#39;t want to be a short seller of MLTX!

FlyingChemist01

Lindzcav

GreenShieldTraders

Lisajane

Modern_portholio_theory

Patrick D'Ambrosio

Sandra Thomas

septrading

Obidagreat

Impossible Pub

Haud L Richards

whatsinaname

MichaelReis

jay higginbotham

Derek Edwards

Vern Bannister

Mani

MoneyHoff

Kenneth Bishop

Brian Perry

Hannah May

John Henry

Geraad

Ένη Δημ

Thomas

Teaz Brown

GrumpyCrow

George Moreno

acom01

StockTwits Web

Stock Karate

StockTwits for iOS

MoonLake Immunotherapeutics

 
Today, as expected, all positive news. By July they'll report expedited approval process from the FDA on top of additional positive trial results. 

SLK is the only small molecule NanoBody for Inflammatory skin diseases, this simply places it as superior to everything else.

There's literally nothing standing in SLK's path to becoming Best in Class across all Inflammatory skin disease indications. Furthermore, we have zero concern of dilution which almost always happens during phase 3 trials nearing drug BLA submission. 

Wouldn't want to be a short seller of MLTX!

K J Lays

@Creisi like the optimistic views...im really looking forward to some real movement on good results for a change.

StockTwits For Android 

 like the optimistic views...im really looking forward to some real movement on good results for a change.

Jon and Maria Marti

midas7576

The FDA are firmly behind SLK and already see it as a high efficacy, best in class treatment which employs far better modern medicine. The labelling advantages are huge.

When the FDA backs a drug, like they do with SLK, its future is all green. The labelling and marketing materials advantage already confirmed is a Big Pharma dream marketing package....  and will immediately push SLK into the $BILLIONS of annual revenue projections.

$MLTX will never sell for under $100/share. Thats literally a lock given the April 1st FDA feedback. 

I find it very peculiar MLTX has not detailed a marketing name; which obviously supports the notion they are leaving this to their future owner.

Ken Slamcock

Hai Nguyen

Dusko Dakic

perplex

Alan Purdie

Adriaan

Belana

The FDA are firmly behind SLK and already see it as a high efficacy, best in class treatment which employs far better modern medicine. The labelling advantages are huge.

When the FDA backs a drug, like they do with SLK, its future is all green. The labelling and marketing materials advantage already confirmed is a Big Pharma dream marketing package....  and will immediately push SLK into the $BILLIONS of annual revenue projections.



 will never sell for under $100/share. Thats literally a lock given the April 1st FDA feedback. 

I find it very peculiar MLTX has not detailed a marketing name; which obviously supports the notion they are leaving this to their future owner.

@Creisi Last point is mighty interesting!